The Patent Finder

Takeda Vaccines, Inc.

Also on record
Records under this name other than the patents Takeda Vaccines, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 57 patents it holds.

Back to Takeda Vaccines, Inc.

Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleStatus Expires Confidence
US 9,821,049Method of conferring a protective immune response to Norovirus
Formerly held
In force
 · USPTO record
In forceUSPTO record
US 10,052,374Compositions, Methods and Uses for Dengue Virus SEROTYPE-4 Constructs
Held by another company
In force
 · High confidence
In forceHigh confidence
US 9,408,901Compositions, Methods and Uses for Dengue Virus SEROTYPE-4 Constructs
Formerly held
In force
 · High confidence
In forceHigh confidence
US 10,130,696Method of Conferring a Protective Immune Response to Norovirus
Grace period ended
 · Low confidence
Grace period endedLow confidence
US 9,834,757Hand, foot, and mouth vaccines and methods of manufacture and use thereof
Lapsed on the fee record
Ended Dec 5, 2025 · USPTO record
Lapsed on the fee recordEnded Dec 5, 2025USPTO record
US 10,806,781Compositions and methods for live, attenuated alphavirus formulations
Lapsed on the fee record
Ended Oct 20, 2024 · USPTO record
Lapsed on the fee recordEnded Oct 20, 2024USPTO record
US 10,806,782Hand, foot, and mouth vaccines and methods of manufacture and use thereof
Lapsed on the fee record
Ended Oct 20, 2024 · USPTO record
Lapsed on the fee recordEnded Oct 20, 2024USPTO record
US 10,632,184Compositions and methods for stabilizing alphaviruses with improved formulations
Lapsed on the fee record
Ended Apr 28, 2024 · USPTO record
Lapsed on the fee recordEnded Apr 28, 2024USPTO record
US 9,028,809Compositions, methods and uses for expression of enterobacterium-associated peptides
Lapsed on the fee record
Ended May 12, 2023 · USPTO record
Lapsed on the fee recordEnded May 12, 2023USPTO record
US 9,011,874Compositions, methods and uses for poxvirus elements in vaccine constructs
Lapsed on the fee record
Ended Apr 21, 2023 · USPTO record
Lapsed on the fee recordEnded Apr 21, 2023USPTO record
10 of 23 patents shown.
Pro members see all 23.
Pro members: see all 23 patents
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited